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Background/aim: The possibility of adverse effects of the oral glucose tolerance test (OGTT) carried out for the screening of gestational
diabetes among pregnant women and fetuses is a frequently discussed topic. The purpose of this study was to investigate the effects of
the hyperglycemia peak during OGTT on the levels of oxidants and antioxidants in the body.
Materials and methods: Eighty individuals who applied to the Outpatient Clinic with suspected diabetes and OGTT indication were
included in the study. Glucose, total oxidant capacity status (TOS), total antioxidant capacity (TAS), superoxide dismutase (SOD), and
lipid hydroperoxide (LOOH) levels were tested on blood samples collected from these individuals at 0, 60, and 120 min during the
OGTT carried out with 75 g of glucose. Oxidative stress index (OSI) was calculated as the ratio of TOS to TAS.
Results: While the oxidative parameters TOS and LOOH were significantly increased at 60. min of OGTT, only LOOH was significantly
increased at 120. min of OGTT. Significant decreases in antioxidative parameters (TAS, SOD) were observed at 60. and 120. min of the
OGTT and OSI was significantly increased at 60. and 120. min of the OGTT.
Conclusion: Oxidative stress parameters were increased and antioxidative parameters were decreased during the OGTT. However,
more extended studies are required to determine the effects of the increased oxidative stress on pregnant women and fetuses.
Key words: Oral glucose tolerance test, oxidative parameters, antioxidative parameters, oxidative stress

1. Introduction
Oxidative stress has an important role in the pathogenesis
and late complications of diabetes. As a result of having
one or more unshared electron, free radicals are very
reactive and they tend to grab electrons from other
atoms or molecules to fill their outer energy levels [1]. In
diabetes mellitus, oxidative stress can occur because of the
production of reactive oxygen species (ROS) including
superoxide (O2‒) radical, hydroxide radical (HO‒),
and hydrogen peroxide (H2O2) in high levels and/or
inadequacy of antioxidant defense systems [2]. Increase in
ROS production is related to protein glycosylation and/or
autoxidation of glucose under hyperglycemic conditions.
The reason for the inadequacy of neutralization of free
radicals is related to the inadequacy of enzymatic and
nonenzymatic radical scavengers (antioxidants) [3].
Glucose oxidation, nonenzymatic protein glycation,
and the following oxidative degradation of glycosylated
proteins in diabetes result in the formation of free radicals

in excessive amounts. Free radicals formed in high
amounts in general, simultaneously with the reduction in
the efficiency of antioxidant defense mechanisms, damage
the cellular organelles and enzymes, and cause lipid
peroxidation and increase in insulin resistance. Hence,
oxidative stress may lead to the occurrence of diabetic
complications [4].
Furthermore, a high concentration of glucose in diabetes
causes sorbitol production through the polyol pathway.
Since nicotinamide adenine dinucleotide phosphate
(NADPH) is used for glucose reductase enzyme activity
in this pathway, intracellular NADPH will be consumed
in diabetes. NADPH is required to transform oxidized
glutathione to a reduced form and for the synthesis of
nitric oxide (NO). Therefore, the active sorbitol pathway
and consequently the absence of NADPH will mean the
limitation of the antioxidant capacity [4,5].
Diabetes mellitus is a prevalent disease group in the
general population, and sometimes the oral glucose
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tolerance test (OGTT) is used for diagnostic purposes. The
possibility of the adverse effects of the OGTT carried out
for the screening of gestational diabetes among pregnant
women and fetuses is a frequently discussed topic. The
purpose of this study was to investigate the effects of the
hyperglycemia peak during the OGTT on the levels of
oxidants and antioxidants in the body and the balance
between them in the body.
2. Materials and methods
This prospective, cross-sectional study was conducted
between January 1, 2018, and August 29, 2018, at
the outpatient clinics of the Internal Medicine and
Endocrinology Departments in a tertiary hospital.
The study was approved by the Local Ethics Committee
of the Faculty of Medical Sciences of Yozgat Bozok
University (Protocol Number: 22.04.2016/42). We adhered
to the principles of the Helsinki Declaration during the
study and written informed consent was obtained from all
participants.
2.1. Subjects
Eighty individuals who applied to the Internal Diseases
and Endocrinology and Metabolism Diseases Outpatient
Clinic with suspected diabetes and OGTT indication were
included in the study. These individuals were between 18
and 65 years old and had no previous disease. Glucose,
total oxidant capacity status (TOS), total antioxidant
capacity (TAS), superoxide dismutase (SOD), and lipid
hydroperoxide (LOOH) levels were tested on blood
samples collected from these individuals at 0., 60. and 120.
min during the OGTT carried out with 75 g of glucose.
Oxidative stress index (OSI) was calculated as the ratio of
TOS to TAS (OSI = TOS/TAS). Changes in these parameters
obtained at 0., 60., and 120. min of the OGTT and the
oxidant stress index (OSI) were statistically evaluated.
In addition, patients were divided into 3 groups based
on the OGTT results: Group 1: Normal (baseline glucose
level < 110 mg/dL and glucose level at 120. min of the
OGTT < 140 mg/dL); Group 2: Individuals with impaired
fasting glucose and/or impaired glucose tolerance (glucose
level between 100 mg/dL and 126 mg/dL at baseline and/
or glucose level between 140 mg/dL and 200 mg/dL at 120.
min); Group 3: Diabetic individuals (baseline glucose level
≥ 126 mg/dL or glucose level ≥ 200 mg/dL at 120. min of
the OGTT). Comparison of these groups was performed in
terms of oxidative and antioxidative parameters.
2.2. Blood collection and preparation
Venous blood samples were collected from an antecubital
vein of each patient after a 12-h overnight fast, and a 10
mL sample of venous blood was placed into a biochemistry
tube. Blood samples were withdrawn and sera were
separated with centrifugation at 3000 rpm for 10 min. All
material was stored at –80 °C until analysis.

2.3. Analysis of blood samples
Serum TOS, TAS, LOOH, and SOD were determined with
a Rel Assay Diagnostics Kit (Mega Tıp, Gaziantep, Turkey)
developed by Erel, and OSI values were calculated.
2.4. Determination of total antioxidant status (TAS)
TAS was measured in the serum by the generation of
2,2′-azino-di-(3-ethylbenzothiazoline sulfonate) (ATBS)
radical cation using a commercial kit according to the
manufacturer’s manual.
2.5. Determination of total oxidant status (TOS)
TOS was measured as described by the manufacturer’s
protocol. In this method, the oxidants present in the
sample oxidized the ferrous ion-o-dianisidine complex
to ferric ion. Ferric ion produces a colored complex with
xylenol orange in an acidic medium. The color intensity,
which can be measured spectrophotometrically, is related
to the total amount of oxidant molecules present in the
sample. The assay was calibrated with hydrogen peroxide
and the results were expressed in terms of μmol H2O2
equivalent/L of the serum.
2.6. Measurement of LOOH levels
Serum LOOH levels were measured with ferrous ion
oxidation-xylenol orange (FOX-2) assay, which involves
the oxidation of ferrous ion to ferric ion by various
oxidants. The ferric ion is then measured with xylenol
orange. The LOOH levels are reduced by the application
of triphenylphosphine (TPP), which is a specific reductant
for lipids. LOOH levels can be estimated as the difference
in values in the absence or the presence of TPP.
2.7. Calculation of oxidative stress index (OSI)
The TOS/TAS ratio was used as the oxidative stress index
(OSI) and was calculated as follows: OSI (arbitrary units)
= [(TOS, μmol H2O2/L) / (TAS, mmol Trolox equiv./L)].
2.8. Determination of superoxide dismutase (SOD) activity
The total SOD activity was determined in the serum using
the SOD Activity Assay Kit according to the manufacturer’s
instructions. SOD was measured by utilizing a tetrazolium
salt for detection of superoxide radicals generated by
xanthine oxidase and hypoxanthine. Measurements
of TOS, TAS, LOOH, and SOD were performed on a
Multiscan GO microplate reader (Thermo Scientific,
USA).
2.9. Statistical analysis
All analyses were performed using SPSS version 23.0 (IBM
Corp., Armonk, NY, USA). The suitability of the data
for normal distribution was evaluated by Kolmogorov–
Smirnov and Shapiro–Wilk tests. Quantitative data
showing normal distribution are given as mean and
standard deviation. In comparison between groups, oneway ANOVA was used, and repeated measures ANOVA
was used for comparison of repeated measures. In the
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case of a difference, the post hoc Bonferroni test was
used to find out which group(s) caused the difference.
The relationships between the variables were evaluated by
Pearson correlation test. Statistical significance level was
taken as P <0.05.
3. Results
The OGTT was applied to 80 individuals with OGTT
indication in this study. It was found that glucose, TOS,
LOOH, and OSI reached the highest values at 60. min, and
the values at 120. min were lower than those at 60. min
while they remained high compared to the baseline. It was
also found that TAS and SOD values were lowest at 60.
min and increased at 120. min, while they remained lower
as compared to the baseline (Table 1).
There was no statistically significant difference between
the TOS levels at baseline and 120. min (P = 0.06), while
there were statistically significant differences between the
levels of all the other parameters at the studied time points
(P < 0.05) (Table 2).
All the parameters (glucose, TOS, LOOH, TAS, SOD,
and OSI) were compared at baseline, 60. min, and 120.
min of the OGTT in the 3 groups. A statistically significant
difference was found between the glucose levels (P < 0.05),
while no statistically significant differences were found
between the other parameters (P > 0.05).
When the relationships between glucose and TOS,
LOOH, TAS, SOD, and OSI were evaluated, statistically
significant positive correlations were found between
glucose and TOS, LOOH, and OSI (P < 0.001, r = 0.572;
P < 0.001, r = 0.501; P < 0.001, r = 0.470, respectively) and
statistically significant negative correlations were found
between glucose and TAS and SOD (P < 0.001, r = –0.243
and P = 0.012, r = –0.162, respectively).

However, we were unable to carry out intragroup
evaluations because of the small number of patients in the
groups (25 patients in group 2 and 13 patients in group 3).
4. Discussion
We aimed to evaluate the effect of the hyperglycemic
peak during the OGTT on oxidative stress markers and
we found that oxidative stress parameters were increased
and antioxidative parameters were decreased during the
OGTT in this study.
Guntas Korkmaz et al. [6] investigated TAS and markers
of oxidative stress in subjects with normal or impaired
glucose regulation in patients with diabetes. They found
that hyperglycemia was related to increased ischemiamodified albumin, advanced oxidation protein products,
and prooxidants-antioxidants balance concentrations,
and an increase in glucose concentrations during glucose
loading could cause tissue damage by increasing oxidative
stress. Serin et al. [7] showed that postchallenge 2 h serum
thiobarbituric acid reactive substances and oxidized
low density lipoprotein levels in subjects with impaired
glucose tolerance and in the diabetic glucose tolerance
groups were found to be higher than their baseline levels,
which might suggest that oxidative stress occurs at an early
stage in diabetes. In this study, oxidative stress markers
increased significantly in all the groups and antioxidant
markers decreased significantly. The difference between
the results of the studies could be explained by using
different antioxidative and oxidative stress markers in
determining the oxidative stress status in the body.
Choi et al. [8] investigated 16 plasma markers as
indicators of inflammation and oxidative stress during the
OGTT in 54 individuals. Leptin, retinol-binding protein-4,
CRP, osteopontin, angiogenin, macrophage-derived

Table 1. TOS, LOOH, TAS, SOD, and OSI levels at the baseline, 60. and 120. min in OGTT.
Time (min)
0
(n: 80)

60
(n: 80)

120
(n: 80)

P*

Glucose (mg/dL)

103.33 ± 19.02

188.70 ± 54.93

145.85 ± 50.67

<0.001

TOS

1.77 ± 0.22

2.64 ± 0.39

1.89 ± 0.23

<0.001

LOOH

16.40 ± 2.56

26.97 ± 3.66

19.16 ± 4.07

<0.001

TAS

2.20 ± 0.86

1.61 ± 0.43

1.85 ± 0.47

<0.001

SOD

1.81 ± 0.23

1.50 ± 0.18

1.68 ± 0.25

<0.001

OSI

0.89 ± 0.29

1.80 ± 0.64

1.09 ± 0.33

<0.001

* Repeated measures ANOVA.
TOS (μmol H2O2/L): Total oxidant capacity status; LOOH (μmol/L): Lipid hydroperoxide; TAS
(mmol Trolox equiv./L): Total antioxidant capacity; SOD (U/mL): Superoxide dismutase; OSI:
Oxidative stress index; OGTT: Oral glucose tolerance test.
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Table 2. Comparison of glucose, TOS, LOOH, TAS, SOD and OSI at the
baseline, 60. and 120. min in OGTT.

Glucose (mg/dL)

TOS

LOOH

TAS

SOD

OSI

I (min)

J (min)

Mean difference
(I-J)

P*

0

60

–85.38

<0.001

120

–42.53

<0.001

60

120

42.85

<0.001

0

60

–0.87

<0.001

120

–0.13

0.060

60

120

0.74

<0.001

0

60

–10.57

<0.001

120

–2.77

<0.001

60

120

7.80

<0.001

0

60

0.60

<0.001

120

0.35

<0.001

60

120

–0.24

<0.001

0

60

0.31

<0.001

120

0.14

<0.001

60

120

–0.18

<0.001

0

60

–0.91

<0.001

120

–0.21

<0.001

120

0.70

<0.001

60

* Bonferroni post hoc test.
TOS (μmol H2O2/L): Total oxidant capacity status; LOOH (μmol/L): Lipid
hydroperoxide; TAS (mmol Trolox equiv./L): Total antioxidant capacity;
SOD (U/mL): Superoxide dismutase; OSI: Oxidative stress index; OGTT:
Oral glucose tolerance test.

chemokine, and macrophage colony stimulating factor
concentrations significantly decreased during the OGTT,
while IL-6, IL-8, and monocyte chemoattractant protein-3
concentrations significantly increased during the OGTT,
which might support that glucose ingestion has an impact
on systemic inflammation and oxidative stress. Manning
et al. [9] measured the levels of inflammatory cytokines
(IL-6, TNF-α) and peroxides as oxidative stress markers
during the OGTT performed for 33 overweight or obese
individuals at 0., 30., 60., 90., and 120. min. They found
that IL-6 decreased at 30. and 60. min, while peroxides
decreased significantly at 60. min as compared to the
baseline. Contrary to the results of this study, we found
that oxidative stress markers (TOS, LOOH) significantly
increased.
Andreeva-Gateva et al. [10] investigated SOD,
glutathione, and TAS levels as antioxidant parameters
in 36 healthy volunteers and 36 patients with metabolic
syndrome at 0., 60. and 120. min of the OGTT. They found
significant decreases in SOD and glutathione peroxidase

activity at 120. min in both groups while the TAS was
increased significantly at 120. min. In this study, the TAS
value was significantly lower at both 60. and 120. min.
Ceriello et al. [11] demonstrated that antioxidant
defenses were reduced during the OGTT both in normal
and noninsulin-dependent diabetic subjects. Similarly, we
also found that the OGTT resulted in a significant decrease
in antioxidant defense in both diabetic and nondiabetic
patients in this study. Nakanishi et al. [12] examined
serum glucose and urine isoprostane as oxidative stress
markers at the baseline, the 1st hour, and the 2nd hour of
the 75 g OGTT in 775 Japanese-American individuals who
had normal glucose tolerance, impaired glucose tolerance,
or diabetes. They found glucose excursion might lead to
oxidative stress, which is similar to the results of this study.
Muratoğlu et al. evaluated the effect of the 50 g
glucose challenge test (GCT) on thiol/disulfide balance
in 100 women at 24–28 weeks of gestation [13]. The
glucose load increased oxidative stress by changing the
thiol/disulfide homeostasis in GCT-positive pregnant
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individuals while not in healthy pregnancies. Gelaleti et
al. demonstrated that increased oxidative DNA damage
was present in patients with overt gestational diabetes
and mild gestational hyperglycemia [14]. On the other
hand, Rueangdetnarong et al. [15] compared the levels
of oxidative stress biomarkers between pregnancies with
gestational diabetes mellitus (GDM) or without GDM.
They reported that pregnancies with GDM had increased
oxidative stress and apoptosis markers levels, which were
not correlated with pregnancy outcomes. Better glycemic
control did not prevent the increase in oxidative stress.
Biomarker levels in cord blood of pregnant women with
GDM were not altered, which suggested that the placenta
could be the barrier for the oxidative stress and cytokines.
Although there are many studies carried out on many
patient groups using many biomarkers to evaluate the
relationship between the OGTT and oxidative stress and
their effects on the human body, diverse results have been
reported, some of which are contrary to each other. In our
opinion, such different results may be mainly attributed
to the use of many diverse antioxidative and oxidative
stress markers to determine the oxidative stress status of
the body. To avoid this, reaching a consensus on which
antioxidative and oxidative stress markers should be used

to determine the oxidative stress status of the body, and
measuring these determined markers, will be a good
approach.
We aimed to address the issue of whether to perform
the OGTT in pregnant women for screening purposes.
When planning the study, we were hoping to find out
that OGTT screening would not result in any significant
increase in oxidative stress in humans and conclude that
the OGTT could also be safely carried out in pregnant
women. However, we found that the OGTT increased
oxidative parameters and decreased antioxidative
parameters in humans, consequently causing an increase
in oxidative stress. However, since we did not evaluate
whether these biomarkers are present in cord blood of
pregnant women, we do not know their effects on fetuses.
This will require further studies regarding the effects of
the OGTT on humans and particularly on pregnant
women, whether the oxidative stress in the pregnant
women affects fetuses or not, and, if it does, what the
effects will be. Furthermore, studies are also required to
determine whether the hyperglycemia peak caused by the
OGTT in pregnant women will result in a hyperglycemia
peak in the fetus, and if it does, whether oxidative stress
and possible related damage will result.

References
1.

Halifeoğlu İ, Karataş F, Çolak R, Canatan H, Telo S. Tip 2
Diyabetik Hastalarda Tedavi Öncesi ve Tedavi Sonrası Oksidan
ve Antioksidan Durum. Fırat Medical Journal 2005; 10 (3):
117-122 (in Turkish).

7.

Serin O, Konukoglu D, Fırtına S, Maviş O. Serum oxidized low
density lipoprotein, paraoxonase 1 and lipid peroxidation levels
during oral glucose tolerance test. Hormone and Metabolic
Research 2007; 39 (3): 207-211. doi: 10.1055/s-2007-970419.

2.

Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G et
al. Lipid peroxidation and antioxidant enzyme status in Type
2 diabetics with coronary heart disease. Diabetes Research
and Clinical Practice 2001; 53 (1): 33-39. doi: 10.1016/S01688227(01)00238-8.

8.

3.

Hunt JV, Smith CC, Wolff SP. Autoxidative glycosylation and
the possible involvement of peroxides and free radicals in LDL
modification by glucose. Diabetes 1990; 39 (11): 1420-1424.
doi: 10.2337/diab.39.11.1420.

Choi HJ, Jeon SY, Hong WK, Jung SE, Kang HJ et al. Effect
of glucose ingestion in plasma markers of inflammation and
oxidative stress: analysis of 16 plasma markers from oral
glucose tolerance test samples of normal and diabetic patients.
Diabetes Research and Clinical Practice 2013; 99: 27-31. doi:
10.1016/j.diabres.2012.01.005.

9.

4.

Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative
stress, and antioxidants: Review. Journal of Biochemical
and Molecular Toxicology 2003; 17 (1): 24-38. doi: 10.1002/
jbt.10058.

Manning PJ, Sutherland WHF, Walke RJ, De Jong SA, Berry
EA. The effect of glucose ingestion on inflammation and
oxidative stress in obese individuals. Metabolism Clinical
and Experimental 2008; 57: 1345-1349. doi: 10.1016/j.
metabol.2008.04.020.

10.

Andreeva-Gateva P, Popova D, Orbetsova V. Antioxidant
parameters in metabolic syndrome–a dynamic evaluation
during oral glucose tolerance test. Vutr Boles 2001; 33(2-3):
48-53 (in Bulgarian with an abstract in English).

11.

Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzion S et
al. Antioxidant defenses are reduced during the oral glucose
tolerance test in normal and non-insulin-dependent diabetic
subjects. European Journal of Clinical Investigation 1998; 28:
329-333. doi: 10.1046/j.1365-2362.1998.00295.x.

5.

6.

Altan N, Dinçel AS, Koca C. Diabetes mellitus and oxidative
stress. Turkish Journal of Biochemistry 2006; 31 (2): 51-56 (in
Turkish with an abstract in English).
Guntas Korkmaz G, Konukoglu D, Kurtulus EM, Irmak
H, Bolayirli M et al. Total antioxidant status and markers of
oxidative stress in subjects with normal or impaired glucose
regulation (IFG, IGT) in diabetic patients. Scandinavian
Journal of Clinical & Laboratory Investigation 2013; 73: 641649. doi: 10.3109/00365513.2013.846477.

1746

YILDIRIM et al. / Turk J Med Sci
12.

Nakanishi S, Yoneda M, Maeda S. Impact of glucose excursion
and mean glucose concentration in oral glucose tolerance
test on oxidative stress among Japanese Americans. Diabetes,
Metabolic Syndrome and Obesity: Targets and Therapy 2013;
6: 427-433. doi: 10.2147/DMSO.S53760.

14.

Gelaleti RB, Damasceno DC, Ortiz Lima PH, Favero Salvadori
DM, Paranhos Calderon IM et al. Oxidative DNA damage
in diabetic and mild gestational hyperglycemic pregnant
women. Diabetology & Metabolic Syndrome 2015, 7: 1. doi:
10.1186/1758-5996-7-1.

13.

Mertoğlu C, Gunay M, Siranli G, Kulhan M, Gok G et al. The
effect of the 50 g glucose challenge test on the thiol/disulfide
homeostasis in pregnancy. Fetal and Pediatric Pathology 2018;
37 (3): 147-156. doi: 10.1080/15513815.2018.1453002.

15.

Rueangdetnarong H, Sekararithi R, Jaiwongkam T, Kumfu
S, Chattipakorn N et al. Comparisons of the oxidative stress
biomarkers levels in gestational diabetes mellitus (GDM) and
non-GDM among Thai population: cohort study. Endocrine
Connections 2018; 7: 681-687. doi: 10.1530/EC-18-0093.

1747

